Trial Profile
Controlled, prospective, multicentre, open, randomized study to investigate the contraceptive efficacy, bleeding patterns, metabolic effects, cycle-associated complaints, acceptance, and safety of an oral contraceptive containing 30 µg ethinylestradiol and 150 µg levonorgestrel, in two different regimens of intake (4 extended cycles of 91 days versus 13 conventional cycles of 28 days) in healthy women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Apr 2021
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Acronyms Lisa Lang Study
- Sponsors Madaus
- 23 Aug 2016 Status changed from recruiting to completed.
- 17 Mar 2016 New trial record